# Rubi Laboratories

> Enzyme-based manufacturing of materials from carbon inputs.

## Why it is interesting

The company's offtake term sheets indicate commercial interest; they are not recognised revenue or evidence of delivered production.

## Profile

- **Latest funding:** Undisclosed stage — $7.5M financing (March 17, 2026)
- **Latest known valuation:** Not publicly disclosed
- **Total disclosed equity funding:** $7.5M
- **Stage:** N/A
- **Status:** private
- **Industries:** N/A
- **Coverage:** stub
- **Last updated:** 2026-10-28
- **Latest funding investors:** AP Ventures, FH One Investments, Talis Capital, CMPC Ventures, H&M Group, Understorey Ventures

## Key facts

- AP Ventures portfolio classification: current, checked October 28, 2026. This is a manager-reported status, not an ownership percentage.
- Funding history covers the source-verified transactions recorded here; it is not a complete lifetime financing total.

## Funding history

- Undisclosed stage · $7.5M financing · March 17, 2026
  Source: https://www.prnewswire.com/news-releases/rubi-raises-7-5m-and-secures-over-60m-in-offtake-term-sheets-advancing-commercialization-of-its-breakthrough-co2-to-materials-platform-302715833.html

## Investors in our directory

- https://venturecapitaltracker.com/fund/ap-ventures

## Related articles

- https://venturecapitaltracker.com/ap-ventures-portfolio-companies-strategy

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** October 28, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/startup/rubi-laboratories